Skip to main content
BCAX logo

BCAX · Bicara Therapeutics Inc. · Debt

Track BCAX — free
$17.65 +0.39 (+2.23%)
Market Cap
$1.17B
Shares
66.17M
Volume · Oct 9 262.24K Avg daily vol (3M) 620.37K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 1,163,000 10-Q filed 2026-08-11
Noncurrent operating lease liabilities 2026-06-30 USD 0 10-Q filed 2026-08-11
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 2023658 CUSIP 055477103 13F (30d) 6 filings 6 filers Visit website Investor relations